Category Archives: Wholesale Pharmacy

SILVER SPRING, Md., March 4, 2013 /PRNewswire/ --Pharmagen, Inc. (PHRX) (the "Company" or "Pharmagen") announces it has entered into a financial advisory agreement with Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (MERR). Merriman Capital, Inc. is a registered investment bank providing equity and options execution services, market making, and differentiated research for high growth companies. The firm also provides capital raising, advisory, and M&A services. Under the terms of the agreement, Merriman has agreed to provide Pharmagen with a wide range of services from equity research coverage, participation in the Merriman's annual investor conference, non-deal road shows and eligibility criteria for admission to NASDAQ and other exchanges. Merriman is the leading investment banking firm for micro-cap companies. "Pharmagen continues to demonstrate to our shareholders that we are building a company for the long term. Merriman is the leading advisory firm to companies in our market cap range and we're going to work very hard over the coming year to build an institutional shareholder base. Merriman is going to ensure that we're doing it in a way that will resonate with that community," said Mackie A. Barch, CEO of Pharmagen. About Pharmagen Pharmagen, Inc. ("Pharmagen"), and wholly … Continue reading →

MINNEAPOLIS--(BUSINESS WIRE)-- SUPERVALU (SVU) today announced several changes to its executive and banner retail leadership teams, as it continues preparations to move forward with a focus on serving wholesale grocery operators, growing its hard discount format and running a smaller, more efficient retail operation following the close of its previously announced transaction with AB Acquisition LLC. That transaction is expected to be completed the week of March 18, 2013. Todays announcement includes additions to SUPERVALUs corporate leadership team as well as new presidents at Save-A-Lot and Shop N Save. There will be additional announcements in the coming weeks as new president and chief executive officer Sam Duncan continues to finalize his leadership team. Corporate Leadership Changes Mark Van Buskirk has been named executive vice president, merchandising and marketing for SUPERVALU, where he will be responsible for overseeing companywide retail merchandising and marketing efforts, along with directing SUPERVALUs private brand offerings and retail pharmacy teams. He spent the past 20 years in leadership positions with Kroger, most recently serving as vice president, meat and seafood merchandising and procurement. Rob Woseth has been named executive vice president, chief strategy officer. In addition to overseeing real estate and corporate development, Woseth will focus … Continue reading →

Following three years of successfully selling the full Trilogy range in John Lewiss flagship Oxford Street store and online, Ecoya (NZX:ECO) announced today that its top-selling Trilogy skincare range will be available in all 27 John Lewis stores throughout Great Britain, in an impressive expansion of its distribution and reach in the UK market. Trilogys Certified Organic Rosehip Oil and Rosehip Oil Antioxidant+ launched in all John Lewis stores last year, and following the outstanding performance of these hero products, Trilogy and John Lewis have entered into a retail agreement to take a capsule collection of Trilogy skincare products into every store. Trilogy Ecoya CEO, Stephen Sinclair, is delighted with the continued growth in distribution and sales. "This is a fantastic result for Trilogy and is testament to the popularity of our high performance natural products with UK customers and the growth potential that exists," he said. The availability of Trilogy products through John Lewiss online store is complementary to its physical retail channels. "Our customers demand a flexible approach. If they cant find the product in store, or if there isnt a stockist in their area, then they will always be able to order online," says Stephen. "Online is … Continue reading →

Many of the major national and multi-national food and beverage companies have started asking their local distributors and wholesale dealers to obtain licenses under the Food Safety and Standards Act (FSSA) 2006. Because, under the Act, vendors and distributors can be held liable for selling products after its date of expiry, misbranding, and storing in unsafe conditions rather than the manufacturer. The Act was notified on August 5, 2011. The process becomes mandatory only by February 4, 2014, as the duration has been extended. The Act (www.fssai.gov.in) states that food business operators functioning without license can be imprisoned for six months and fined up to Rs. 5 lakh. Dealers found selling substandard products are liable to be fined up to Rs. 5 lakh and those selling misbranded products, up to Rs. 3 lakh. Some of these penal provisions, however, have been challenged in various courts. Obtaining these licenses will make the dealer conform to the stringent norms on storage, transporting, and distributing food products. The dealer must know the entire supply chain right up to the manufacturer. In the district around 1,750 dealers had obtained licenses and 6,500 had registered themselves. Conforming to the Act will ensure that high food … Continue reading →

CINCINNATI, February 19, 2013 - Omnicare, Inc. (OCR) reported today financial results for its fourth quarter and full year ended December 31, 2012. Fourth-Quarter Highlights: Adjusted cash earnings per diluted share from continuing operations 10.3% higher to $0.86; GAAP earnings per diluted share of $0.54 Cash flows from continuing operations of $128 million Full-Year Highlights: Adjusted cash earnings per diluted share from continuing operations 15.9% higher to $3.36; GAAP earnings per diluted share of $1.73 Cash flows from continuing operations of $544 million "We are pleased with our progress throughout 2012, in which we generated double-digit adjusted cash earnings per diluted share growth in every quarter," said John L. Workman, Omnicare`s Chief Executive Officer. "During the fourth quarter, we continued to leverage our scale position in our Long-Term Care Group to capitalize on the increased utilization of low-cost generic drugs, while also driving robust results within the manufacturer-focused platforms of our Specialty Care Group." Fourth-Quarter Results Financial results from continuing operations for the quarter ended December 31, 2012, as compared with the same prior-year period, were as follows: More here: Omnicare Reports Fourth-Quarter and Full-Year 2012 Financial Results; Company Provides Full-Year 2013 Guidance … Continue reading →

BUFFALO GROVE, Ill.--(BUSINESS WIRE)-- Safco Dental Supply Company, one of the nations leading suppliers of dental products, today announced that it has achieved the Verified-Accredited Wholesale Distributors (VAWD) accreditation for pharmaceutical wholesale distribution from the National Association of Boards of Pharmacy. The repeat VAWD accreditation demonstrates Safcos commitment to providing protection to customers against receiving counterfeit or contaminated drugs. Achieving the VAWD accreditation is an important, proactive step in ensuring Safcos operating processes and procedures are efficient, legitimate and secure,said John Fuerst, President of Safco. As a leading provider of dental supplies, it is critical to confirm that the proper best practices for safely distributing pharmaceuticals are in place to best protect our customers and provide them with the highest level of service. VAWD is an accreditation program for wholesale medical (pharmaceutical) distributors. Once every three years, VAWD conducts a wide-ranging onsite inspection of physical storage and distribution operations and company policies. Then every year, Safco signs an affidavit stating it has maintained all state licenses and the company is following the recorded policies and procedures approved by VAWD during the last certification process. Safco chooses to participate in the yearly VAWD accreditation in order to comply with the licensing … Continue reading →

Tuesday, February 12, 2013 Eight young ladies are confirmed to join the Ms. Pusong Pinoy, the beauty pageant that will highlight the annual Valentine event of the United Filipino Organization. Renita Shanel Fleming, Carla Camille Flores, Jasmine Guanzon, Stevie Jocelyn Jeter, Melody Johnson, Gilda Maria Ogarro, Roshiel Pascubillo, and Nelly Rose Saturno will vie for the tiara, a gift pack, and $300 cash prize on Sunday, Feb. 17, at the Garapan Fishing Base. The festival itself will run from 7am to 10pm. Besides the grand prize, the first runner-up will get $200 while the second runner-up will get $100, with both receiving gift packages. The panel of judges will also determine the winners for special prizes: Best in Island Wear, Best in Talent, Best in Long Gown, Best in National Costume, and Ms. Photogenic. UFO president Annamae Adaza said they still welcome other interested young ladies 14 to 20 years old to sign up for the contest, as well as companies or individuals who want to donate prizes and have the chance to present their contribution at the event. For information, call or text treasurer Lyn Deazeta at 989-3845, assistant treasurer Bok Enano at 287-9756, and choreographers Joel Vallega and … Continue reading →

DW Healthcare Partners Surpasses Target of $250 Million through Offering of Third Healthcare Investment Fund TORONTO and PARK CITY, Utah, Feb. 10, 2013 /CNW/ - DW Healthcare Partners, a healthcare-focused private equity firm, announced today that it has completed fundraising for its third fund ("DWHP III"), which has closed with $265 million of committed capital, exceeding its original target of $250 million . DWHP III investors are comprised of pension plans, foundations, fund of funds, high net-worth individuals and family trusts. (Logo: http://photos.prnewswire.com/prnh/20130210/LA57441LOGO) DWHP Co-Founder and Managing Director, Andrew Carragher said, "Through our partnerships with talented founders and management teams in our portfolio companies, we have been able to sustain a consistent track record of delivering above-average returns to our investors. As a result, we attracted a great deal of interest while fundraising for Fund III and are pleased that we have exceeded our target. We thank all of our limited partners for their commitment to our firm and look forward to forging new partnerships with innovators, founders, and management teams in the healthcare industry". During the fundraising period, DWHP completed three Fund III investments, totaling approximately $80 million . Through these investments, DWHP has become equity partners with Z-Medica, … Continue reading →

NEW YORK, Feb. 7, 2013 /PRNewswire/ --Verizon Communications Inc. (NYSE, Nasdaq: VZ) today announced the election of Gregory D. Wasson, president and chief executive officer of Walgreen Co. (WAG), to the Verizon Board of Directors, effective March 1. "Greg Wasson brings to Verizon an in-depth knowledge of the retail and health care industries," said Lowell C. McAdam, Verizon chairman and chief executive officer. "He offers a unique perspective as the leader of a successful Fortune 50 company focused on innovation, traditional and nontraditional growth, operational and technical excellence, and multichannel integration. We welcome him as a valuable addition to our board." Wasson will bring Verizon's total board membership to 13. Wasson has been Walgreens president and CEO, and has served as a Walgreens director, since February 2009. Walgreen Co. is based in Deerfield, Ill., and together with its subsidiaries operates the largest drugstore chain in the U.S., with $71.6 billion in net sales, 8,385 locations and 240,000 employees in fiscal 2012. Wasson joined Walgreens as a pharmacy intern in 1980, and after earning his bachelor's degree from Purdue University in 1981 he managed several Houston Walgreens drugstores before being promoted to district manager in 1986. He was promoted to a … Continue reading →

SAN DIEGO (AP) - A Florida man has pleaded guilty in San Diego to running a scheme that sold more than $7 million worth of unapproved cancer drugs. UT San Diego (http://bit.ly/WPbfqU ) says Martin Bean of Boca Raton pleaded to a conspiracy charge on Tuesday in federal court. Prosecutors say Bean bought unapproved drugs from manufacturers in Turkey, India and Pakistan then took orders from doctors through his website and sold them at a steep discount. The drugs were funneled through a San Diego company with a wholesale pharmacy license to make them seem legitimate. Authorities say Bean sold more than $7 million worth of the drugs from 2005 to 2011. The owner of the San Diego company pleaded guilty to conspiracy last year and faces five years in prison. Information from: UT San Diego, http://www.utsandiego.com Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Visit link: Florida man pleads guilty in cancer drug scheme … Continue reading →